إنتاج البنسلين G بالتخمير

المضاد الحيوي الذي غيّر الطب الحديث

Pharmaceutical & Drug Manufacturing Global Industrial Scale $1.8 billion

نظرة عامة

Penicillin G (benzylpenicillin) is produced by submerged aerobic fermentation of Penicillium chrysogenum in large-scale stirred-tank bioreactors. Since Alexander Fleming's 1928 discovery, industrial production has been refined to achieve yields over 50 g/L through strain improvement and process optimization. The fermentation typically runs for 6-8 days, followed by extraction, purification, and crystallization. Penicillin G serves as a direct therapeutic agent and as the starting material for semi-synthetic penicillins.

العملية الكيميائية

Penicillium chrysogenum is cultivated in 100,000-200,000 liter bioreactors with continuous feeding of glucose and phenylacetic acid as the side-chain precursor. The broth is filtered, extracted with butyl acetate at pH 2-2.5, and crystallized as the potassium salt.

L-Cysteine + L-Valine + Phenylacetic acid → Penicillin G (enzyme-catalyzed biosynthesis via ACV synthetase, isopenicillin N synthase, and acyltransferase)

المواد الخام

  • Glucose (C₆H₁₂O₆) — Corn wet milling (Carbon source)
  • Phenylacetic acid (C₈H₈O₂) — Chemical synthesis (Side-chain precursor)
  • Corn steep liquor — Corn wet milling byproduct (Nitrogen source)

المنتجات النهائية

  • Penicillin G potassium — Injectable antibiotic and semi-synthetic penicillin precursor (>98% purity by HPLC)
  • 6-APA (6-aminopenicillanic acid) — Core structure for semi-synthetic penicillins (Derived by enzymatic cleavage)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Fermentation generates large volumes of mycelial waste and spent broth requiring treatment. Solvent extraction with butyl acetate produces VOC emissions. Modern facilities use solvent recovery and waste biomass composting to reduce environmental impact.

اعتبارات السلامة

الابتكارات الحديثة

Metabolic engineering of Penicillium strains using CRISPR-Cas9 has further improved yields.
Continuous chromatography purification is replacing traditional solvent extraction to reduce chemical waste and improve product quality.

حجم الإنتاج

30000

طن/سنة

$1.8 billion

القيمة السوقية

المزيد في %(name)s Pharmaceutical & Drug Manufacturing

إنتاج الأموكسيسيلين شبه الصنعي

Global Industrial Scale

إنتاج الإنسولين البشري المؤتلف

Global Industrial Scale

تخليق أوميبرازول لمثبطات مضخة البروتون

Global Industrial Scale

تخليق الأسبرين عبر أستلة حمض الساليسيليك

Global Industrial Scale

تخليق الإيبوبروفين — عملية BHC الخضراء

Global Industrial Scale

تخليق الباراسيتامول (الأسيتامينوفين)

Global Industrial Scale

تخليق هيدروكلوريد الميتفورمين

Global Industrial Scale

Frequently Asked Questions

What industry uses إنتاج البنسلين G بالتخمير?
إنتاج البنسلين G بالتخمير is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in إنتاج البنسلين G بالتخمير?
Penicillium chrysogenum is cultivated in 100,000-200,000 liter bioreactors with continuous feeding of glucose and phenylacetic acid as the side-chain precursor. The broth is filtered, extracted with butyl acetate at pH 2-2.5, and crystallized as the potassium salt.
What is the economic significance of إنتاج البنسلين G بالتخمير?
إنتاج البنسلين G بالتخمير has a market value of $1.8 billion and annual production of 30,000 tons.
What is the environmental impact of إنتاج البنسلين G بالتخمير?
Fermentation generates large volumes of mycelial waste and spent broth requiring treatment. Solvent extraction with butyl acetate produces VOC emissions. Modern facilities use solvent recovery and waste biomass composting to reduce environmental impact.
What raw materials are used in إنتاج البنسلين G بالتخمير?
The main raw materials include: Glucose (C₆H₁₂O₆), Phenylacetic acid (C₈H₈O₂), Corn steep liquor.